Do you support this bill?

Assembly Bill A6386

2011-2012 Legislative Session

Requires the drug Leuprolide acetate, to be labeled with a warning of the possible side effects thereof

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

co-Sponsors

multi-Sponsors

2011-A6386 (ACTIVE) - Details

Current Committee:
Assembly Higher Education
Law Section:
Education Law
Laws Affected:
Add ยง6811-c, Ed L

2011-A6386 (ACTIVE) - Summary

Requires the drug Leuprolide acetate, to be labeled with a warning of the possible side effects thereof.

2011-A6386 (ACTIVE) - Bill Text download pdf 

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  6386

                       2011-2012 Regular Sessions

                          I N  A S S E M B L Y

                             March 16, 2011
                               ___________

Introduced  by M. of A. N. RIVERA, CRESPO, AUBRY, COOK, ARROYO, McENENY,
  ENGLEBRIGHT, P. RIVERA, M. MILLER, CASTRO, STEVENSON,  RAMOS,  JAFFEE,
  ROBERTS  --  Multi-Sponsored  by  -- M. of A. CAMARA, DUPREY, LINARES,
  MAISEL, McDONOUGH, MONTESANO, MOYA, ORTIZ, RAIA, J. RIVERA, RODRIGUEZ,
  TOWNS -- read once and referred to the Committee on  Consumer  Affairs
  and Protection

AN  ACT  to  amend  the  education  law,  in relation to the labeling of
  Leuprolide acetate

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. The education law is amended by adding a new section 6811-c
to read as follows:
  S 6811-C. LEUPROLIDE ACETATE. NO PHARMACIST SHALL DISPENSE OR SELL THE
DRUG  LEUPROLIDE  ACETATE,  ALSO  KNOWN  AND  MARKETED AS LUPRON, LUPRON
DEPOT, LUPRON  DEPOT-PED,  VIADUR  AND  ELIQARD,  UNLESS  THE  CONTAINER
CONTAINING  SUCH  DRUG  PROVIDED  TO  THE  CONSUMER  IS LABELED WITH THE
FOLLOWING WARNING:
  "CAUTION: THIS DRUG COULD CAUSE ADVERSE REACTIONS INCLUDING,  BUT  NOT
LIMITED TO, HEART ATTACKS, DIABETES, CONVULSIONS, EXCESSIVE BLEEDING AND
COULD LEAD TO DEATH."
  S  2. This act shall take effect on the first of January next succeed-
ing the date on which it shall have become a law.




 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD08549-01-1

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.